Trigyn Technologies Limited
NSE:TRIGYN.NS
114.11 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 12,796.623 | 12,727.244 | 10,405.835 | 9,854.142 | 9,105.458 | 8,946.456 | 6,845.134 | 6,791.529 | 6,254.079 | 4,928.934 | 4,517.083 | 3,483.196 | 2,739.356 | 2,345.472 | 1,946.167 | 1,613.514 | 1,196.305 |
Cost of Revenue
| 8,221.52 | 7,935.59 | 6,746.084 | 6,357.548 | 5,725.608 | 5,729.212 | 4,791.202 | 4,687.242 | 29.457 | 3,354.638 | 3,943.956 | 3,143.441 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 4,575.103 | 4,791.654 | 3,659.751 | 3,496.594 | 3,379.85 | 3,217.244 | 2,053.932 | 2,104.287 | 6,224.622 | 1,574.296 | 573.126 | 339.755 | 2,739.356 | 2,345.472 | 1,946.167 | 1,613.514 | 1,196.305 |
Gross Profit Ratio
| 0.358 | 0.376 | 0.352 | 0.355 | 0.371 | 0.36 | 0.3 | 0.31 | 0.995 | 0.319 | 0.127 | 0.098 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 3,139.876 | 2,340.997 | 1,988.896 | 1,981.172 | 1,875.335 | 1,342.289 | 1,329.927 | 80.416 | 5.134 | 60.205 | 50.597 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 4.053 | 2.418 | 1.424 | 1.969 | 3.445 | 6.463 | 10.161 | 1.617 | 1.372 | 17.736 | 13.131 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 4,296.356 | 3,143.929 | 2,343.415 | 1,990.32 | 1,983.141 | 1,878.78 | 1,348.752 | 1,340.088 | 82.032 | 6.506 | 122.324 | 88.926 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 119.93 | 2.98 | 14.107 | 7.131 | 13.365 | 0.638 | 103.827 | 0.28 | 0.002 | 0.405 | 0.815 | 7.668 | 3.156 | 2.546 | 4.9 | 10.676 | 11.881 |
Operating Expenses
| 4,296.356 | 4,233.68 | 3,068.327 | 2,595.46 | 2,606.222 | 2,383.612 | 1,452.579 | 1,438.201 | 5,604.789 | 4,562.514 | 4,095.745 | 3,269.277 | 2,591.164 | 2,219.374 | 1,849.814 | 1,506.328 | 1,131.715 |
Operating Income
| 278.747 | 569.494 | 611.675 | 896.11 | 750.107 | 832.278 | 599.579 | 666.086 | 620.961 | 401.214 | 980.702 | 213.919 | 148.192 | 126.098 | 96.353 | 148.194 | 83.631 |
Operating Income Ratio
| 0.022 | 0.045 | 0.059 | 0.091 | 0.082 | 0.093 | 0.088 | 0.098 | 0.099 | 0.081 | 0.217 | 0.061 | 0.054 | 0.054 | 0.05 | 0.092 | 0.07 |
Total Other Income Expenses Net
| 103.359 | 12.856 | -23.389 | -6.027 | 26.871 | -48.043 | -1.053 | -3.33 | 1.13 | 35.199 | 560.179 | 24.942 | 7.461 | 14.852 | 14.042 | 41.008 | 19.041 |
Income Before Tax
| 382.106 | 582.35 | 588.286 | 890.083 | 776.978 | 784.235 | 598.526 | 662.756 | 620.963 | 401.619 | 981.517 | 238.861 | 155.654 | 140.95 | 110.395 | 148.194 | 83.631 |
Income Before Tax Ratio
| 0.03 | 0.046 | 0.057 | 0.09 | 0.085 | 0.088 | 0.087 | 0.098 | 0.099 | 0.081 | 0.217 | 0.069 | 0.057 | 0.06 | 0.057 | 0.092 | 0.07 |
Income Tax Expense
| 182.473 | 235.578 | 197.566 | 268.354 | 275.942 | 299.708 | 203.83 | 272.393 | 235.79 | 156.867 | 174.12 | 82.325 | 48.276 | 31.291 | 14.652 | 5.887 | 6.168 |
Net Income
| 199.633 | 346.772 | 390.72 | 621.729 | 501.036 | 484.527 | 394.697 | 390.363 | 385.173 | 244.752 | 807.397 | 156.536 | 107.378 | 421.569 | 95.743 | 142.308 | 77.464 |
Net Income Ratio
| 0.016 | 0.027 | 0.038 | 0.063 | 0.055 | 0.054 | 0.058 | 0.057 | 0.062 | 0.05 | 0.179 | 0.045 | 0.039 | 0.18 | 0.049 | 0.088 | 0.065 |
EPS
| 6.48 | 11.26 | 12.69 | 20.2 | 16.28 | 15.98 | 13.22 | 13.15 | 26.06 | 8.32 | 27.51 | 5.33 | 3.69 | 15.89 | 3.82 | 5.69 | 3.1 |
EPS Diluted
| 6.48 | 11.26 | 12.69 | 20.11 | 16.23 | 15.9 | 12.8 | 12.77 | 25.24 | 8.26 | 27.38 | 5.33 | 3.61 | 15.5 | 3.42 | 5.54 | 3.08 |
EBITDA
| 347.515 | 660.728 | 671.726 | 942.501 | 834.816 | 843.464 | 610.401 | 671.368 | 631.458 | 392.127 | -87.567 | 222.099 | 198.679 | 135.683 | 106.672 | 117.409 | 72.416 |
EBITDA Ratio
| 0.027 | 0.052 | 0.065 | 0.096 | 0.092 | 0.094 | 0.089 | 0.099 | 0.101 | 0.08 | -0.019 | 0.064 | 0.073 | 0.058 | 0.055 | 0.073 | 0.061 |